Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device ...
SUNY Poly Assistant Professor Dr. Amit Sangwan and colleagues recently published research titled "Feasibility Testing of the ...
Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device ...
Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) anticoagulant, today highlighted a key opinion leader presen ...
Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device (CF-LVAD) to sustain heart function. However, despite improvements managing ...
CARMAT's Aeson® artificial heart is gradually becoming a reference solution for bridge to transplant in Europe.